| KRAS Target Exons Screening |
MG3051 |
Tumor Positive Tissue or FFPE Block [Formalin fix (10 percent neutral buffered formalin) and paraffin embed tissue] |
Tue,Fri |
10 days |
Molecular Genetics |
| KRAS Two Mutation Analysis |
MG3052 |
Daily |
7 days |
7 days |
Molecular Genetics |
| LHB Mutation Test [Trp8Arg & Ile15Thr] |
MG3114 |
5 ml Blood in K2/K3 EDTA Tube (LCT) |
Daily |
7 days |
Molecular Genetics |
| mdsFiSH - Microdeletion DiGeorge-VCFS (22q) (AF) |
CG2034 |
10 ml Amniotic Fluid in Sterile Culture Tube |
Daily |
10 days |
Cytogenetics |
| mdsFISH - Microdeletion DiGeorge-VCFS (22q) (POC) |
CG2035 |
POC in Sterile Specimen Container (SSC) having Saline+5 drops gentamycin |
Daily |
10 days |
Cytogenetics |
| mdsFiSH - Microdeletion DiGeorge-VCFS (22q) (VB) |
CG2036 |
2 ml Fetal/ Cord Blood Sod. Heparin Tube (GCT) |
Daily |
10 days |
Cytogenetics |
| mdsFiSH - Microdeletion Miller Dieker Syndrome (17p13.3) (AF) |
CG2037 |
mdsFiSH - Microdeletion Miller Dieker Syndrome (17p13.3) [AF] |
Daily |
10 days |
Cytogenetics |
| mdsFiSH - Microdeletion Miller Dieker Syndrome (17p13.3) (VB) |
CG2038 |
5 ml Venous Blood Sod. Heparin Tube (GCT) |
Daily |
15 days |
Cytogenetics |
| mdsFiSH - Microdeletion Smith-Magenis (17p11.2) (AF) |
CG2039 |
10 ml Amniotic Fluid in Sterile Culture Tube |
Daily |
10 days |
Cytogenetics |
| mdsFiSH - Microdeletion Smith-Magenis (17p11.2) (VB) |
CG2040 |
5 ml Venous Blood Sod. Heparin Tube (GCT) |
Daily |
15 days |
Cytogenetics |
| mdsFISH - Microdeletion Williams syndrome (7q11.2) (AF) |
CG2041 |
10 ml Amniotic Fluid in Sterile Culture Tube |
Daily |
10 days |
Cytogenetics |
| mdsFISH - Microdeletion Williams syndrome (7q11.2) (VB) |
CG2042 |
5 ml Venous Blood Sod. Heparin Tube (GCT) |
Daily |
15 days |
Cytogenetics |
| mdsFISH - Microdeletion Wolf-Hirchhorn Syndrome (4p16 ) (AF) |
CG2043 |
10 ml Amniotic Fluid in Sterile Culture Tube |
Daily |
10 days |
Cytogenetics |
| mdsFISH - Microdeletion Wolf-Hirchhorn Syndrome (4p16 ) (VB) |
CG2044 |
5 ml Venous Blood Sod. Heparin Tube (GCT) |
Daily |
15 days |
Cytogenetics |
| mdsFiSH-Microdeletion Prader Willi / Angelman Syndrome (15q) (AF) |
CG2045 |
10 ml Amniotic Fluid in Sterile Culture Tube |
Daily |
10 days |
Cytogenetics |
| mdsFiSH-Microdeletion Prader Willi / Angelman Syndrome (15q) (POC) |
CG2046 |
POC in Sterile Specimen Container (SSC) having Saline+5 drops gentamycin |
Daily |
10 days |
Cytogenetics |
| mdsFiSH-Microdeletion Prader Willi / Angelman Syndrome (15q) (VB) |
CG2047 |
5 ml Venous Blood Sod. Heparin Tube (GCT) |
Daily |
15 days |
Cytogenetics |
| MITO - Leigh syndrome Target Mutation Analysis |
MG3115 |
5ml Blood in K2/K3 EDTA Tube (LCT) |
Daily |
3 weeks |
Molecular Genetics |
| MITO - LHON Target Mutation Analysis (Leb Hered Optic atrophy ) |
MG3116 |
5ml Blood in K2/K3 EDTA Tube (LCT) |
Daily |
3 weeks |
Molecular Genetics |
| MITO - MELAS Target Mutation Analysis |
MG3117 |
5ml Blood in K2/K3 EDTA Tube (LCT) |
Daily |
10 days |
Molecular Genetics |
| MITO - MERRF Target Mutation Analysis (MT-TK - m.8344A>G) |
MG3118 |
5ml Blood in K2/K3 EDTA Tube (LCT) |
Daily |
10 days |
Molecular Genetics |
| MITO-NARP Target Mutation Analysis (Neuropathy, ataxia, and retinitis pigmentosa) |
MG3119 |
5ml Blood in K2/K3 EDTA Tube (LCT) |
Daily |
10 days |
Molecular Genetics |
| MPL1 Mutation Analysis (Myeloproliferative Leukemia) |
MG3054 |
5 ml Blood or 3 ml Bone marrow in K2/K3 EDTA Tube (LCT) |
Daily |
7 days |
Molecular Genetics |
| MTHFR Two Mutation Test (C677T & A1298C) |
MG3055 |
5 ml Blood in K2/K3 EDTA Tube (LCT) |
Daily |
7 days |
Molecular Genetics |
| Myotonic dystrophy (DM) Molecular Analysis |
MG3056 |
5ml Blood in K2/K3 EDTA Tube (LCT) |
Daily |
15 days |
Molecular Genetics |
| Nonsyndromic Hearing loss Mutation Analysis (Connexin-26) |
MG3120 |
5ml Blood in K2/K3 EDTA Tube (LCT) |
Daily |
15 days |
Molecular Genetics |
| NPM1 Mutation Analysis |
MG3057 |
5 ml Blood or 3 ml Bone marrow in K2/K3 EDTA Tube (LCT) |
Wed, Sat |
5 days |
Molecular Genetics |
| NRAS Target Exon Sequence Analysis |
MG3058 |
Tumor Tissue or FFPE Block |
Mon |
7 days |
Molecular Genetics |
| NUDT15 Genotyping Analysis (Thiopurine induced Toxicity) |
MG3121 |
5ml Blood in K2/K3 EDTA Tube (LCT) |
Daily |
7 days |
Molecular Genetics |
| OncoFiSH - 7q deletion Analysis; (7q22;7q36) MDS & AML |
CG2048 |
5 ml Blood or 3 ml Bone Marrow Sod. Heparin Tube (GCT) |
Daily |
7 days |
Cytogenetics |
| OncoFiSH - ALK Gene Rearrangement |
CG2049 |
FFPE (Formalin Fixed Paraffin Embedded) Tissue Block |
Daily |
12 days |
Cytogenetics |
| OncoFiSH - ATM Deletion; del(11) (q22.3) (NHL) |
CG2066 |
5 ml Blood or 3 ml Bone Marrow Sod. Heparin Tube (GCT) |
Mon, Thu |
7 days |
Cytogenetics |
| OncoFiSH - BCR-ABL1; t(9;22)(q34;q11.2) (CML) |
CG2050 |
5 ml Blood or 3 ml Bone Marrow Sod. Heparin Tube (GCT) |
Daily |
7 days |
Cytogenetics |
| OncoFiSH - cMYC Ampliciation |
CG2070 |
5 ml Blood or 3 ml Bone Marrow Sod. Heparin Tube (GCT); FFPE Block in Sterile Container |
Daily |
7 days |
Cytogenetics |
| OncoFiSH - EGFR Gene Amplification |
CG2051 |
FFPE (Formalin Fixed Paraffin Embedded) Tissue Block |
Daily |
10 days |
Cytogenetics |
| OncoFiSH - ERBB2 (HER-2/neu) Gene Amplification (Breast Cancer) |
CG2052 |
Fresh Tumor tissue, FNA, FFPE (Paraffin Embedded Tissue Blocks) |
Wed, Sat |
10 days |
Cytogenetics |
| OncoFiSH - ETV6-RUNX1 (TEL-AML1); t(12;21) (p13;q22) |
CG2067 |
5 ml Blood or 3 ml Bone Marrow Sod. Heparin Tube (GCT) |
Mon, Thu |
7 days |
Cytogenetics |
| OncoFiSH - FGFR3-IGH Fusion; t(4;14)(p16;q32) (NHL) |
CG2054 |
3 ml Bone Marrow or 5 ml Blood Sod. Heparin Tube (GCT) |
Mon, Thu |
7 days |
Cytogenetics |
| OncoFiSH - IGH Rearrangement; 14q32.3 (ALL / AML) |
CG2055 |
5 ml Blood Sod. Heparin Tube (GCT) |
Mon, Thu |
7 days |
Cytogenetics |
| OncoFiSH - IGH-CCND1 Fusion; t(11;14) Mantle Cell Lymphoma (MCL) |
CG2056 |
3 ml Blood In Sodium Heparin Vacutainer |
Daily |
7 days |
Cytogenetics |
| OncoFiSH - IGH-MYC Dual Fusion t(8;14) (Burkitt\'s Lymphoma) |
CG2057 |
ST: FFPE or Tumor Tissue or FNA; HC: 5 ml Blood or 3 ml Bone marrow in Heparin Tube (GCT) |
Mon, Thu |
7 days |
Cytogenetics |
| OncoFiSH - Inv (16) - CBFB Inversion; t(16;16) (p13;q22) (AML) |
CG2058 |
5 ml Blood Sod. Heparin Tube (GCT) |
Mon, Thu |
6 days |
Cytogenetics |
| OncoFiSH - KMT2A (MLL) Break-apart Analysis; 11q23 (AML & ALL) |
CG2059 |
5 ml Blood or 2 ml Bone Marrow Sod.Heparin Tube (GCT) |
Mon, Thu |
7 days |
Cytogenetics |
| OncoFiSH - MYC Break-apart Analysis; 8q24 (B-cell malignancies) |
CG2060 |
5 ml Blood or 3 ml Bone Marrow Sod. Heparin Tube (GCT); FFPE Block in Sterile Container |
Daily |
7 days |
Cytogenetics |
| OncoFiSH - PML-RARA; t(15;17) (q22;q21.1) (AML) |
CG2064 |
5 ml Blood or 2 ml Bone Marrow Sod.Heparin Tube (GCT) |
Daily |
7 days |
Cytogenetics |
| OncoFiSH - RB1-LAMP; 13q34 Deletion |
CG2061 |
5 ml Blood or 2 ml Bone Marrow Sod.Heparin Tube (GCT) |
Mon, Thu |
7 days |
Cytogenetics |
| OncoFiSH - RUNX1T1-RUNX1 (ETO-AML1); t(8;21) (AML) |
CG2065 |
5 ml Blood or 3 ml Bone Marrow Sod. Heparin Tube (GCT) |
Daily |
7 days |
Cytogenetics |
| OncoFiSH - TP53 Deletion ; 17p13 Deletion (CLL) |
CG2062 |
5 ml Blood or 2 ml Bone Marrow Sod.Heparin Tube (GCT) |
Mon, Thu |
7 days |
Cytogenetics |
| OncoFiSH ALK1-ROS1 Rearrangement (FISH for Non Small Cell Lung Cancer-NSCLC) |
CG2053 |
FFPE Block; Fresh Tumor Tissue in Normal Saline; FNA on Slide |
Daily |
12 days |
Cytogenetics |
| PAI-1 Mutation Analysis (4G/5G allele) |
MG3059 |
5ml Blood in K2/K3 EDTA Tube (LCT) |
Daily |
7 days |
Molecular Genetics |
| PDGFR Alpha Gene Rearrangement; 4q12 |
CG2068 |
5 ml Blood or 3 ml Bone Marrow Sod. Heparin Tube (GCT) |
Daily |
8 days |
Cytogenetics |
| PDGFR Beta Gene Rearrangement; 5q33 |
CG2069 |
5 ml Blood or 3 ml Bone Marrow Sod. Heparin Tube (GCT) |
Daily |
8 days |
Cytogenetics |
| PDGFRA Target Exon Sequence Analysis |
MG3127 |
5 ml Blood or 3 ml Bone marrow in EDTA Vacut. (PCT) or FFPE or Tumor Tissue or FNA |
Daily |
7 days |
Molecular Genetics |
| PDGFRA Target Exons Sequence Analysis |
MG3060 |
Tumor Positive Tissue or FFPE Block [Formalin fix (10 percent neutral buffered formalin) and paraffin embed tissue] |
Daily |
10 days |
Molecular Genetics |
| Phenytoin Genetic Test |
MG3041 |
5ml Blood or 3 ml Bone Marrow in K2/K3 EDTA Tube (LCT) |
Daily |
10 days |
Molecular Genetics |
| PIK3CA Target Mutation Analysis |
MG3061 |
Tumor Positive Tissue or FFPE Block [Formalin fix (10 percent neutral buffered formalin) and paraffin embed tissue] |
Daily |
7 days |
Molecular Genetics |
| Platinum Drug Response Genetic Test (GSTP1, XRCC1, ERCC2) |
MG3062 |
5 ml Blood or 3 ml Bone marrow in K2/K3 EDTA Tube (LCT) |
Daily |
7 days |
Molecular Genetics |
| Praderwilli Syndrome Methylation PCR |
MG3122 |
5ml Blood in K2/K3 EDTA Tube (LCT) |
Fri |
15 days |
Molecular Genetics |
| Prothrombin Mutation Analysis (G20210A) |
MG3063 |
5ml Blood in K2/K3 EDTA Tube (LCT) |
Daily |
7 days |
Molecular Genetics |
| RET High Risk Mutation (Exon 10 &11) |
MG3064 |
FFPE or Tumor Tissue or FNA; 5ml Blood for Family Screening |
Daily |
7 days |
Molecular Genetics |
| RETT Syndrome Molecular Anaysis (MECP2 Gene Sequencing) |
MG3123 |
5ml Blood in K2/K3 EDTA Tube (LCT) |
Sat |
12 days |
Molecular Genetics |
| SBMA (Spinobulbar Muscular Atrophy) Molecular Analysis |
MG3065 |
5ml Blood in K2/K3 EDTA Tube (LCT) |
Daily |
15 days |
Molecular Genetics |
| SCA-1 Mutation Analysis (SpinoCerebellar Ataxia) |
MG3066 |
5ml Blood in K2/K3 EDTA Tube (LCT) |
Daily |
15 days |
Molecular Genetics |
| SCA-10 Mutation Analysis (SpinoCerebellar Ataxia) |
MG3072 |
5ml Blood in K2/K3 EDTA Tube (LCT) |
Daily |
15 days |
Molecular Genetics |
| SCA-12 Mutation Analysis (SpinoCerebellar Ataxia) |
MG3073 |
5ml Blood in K2/K3 EDTA Tube (LCT) |
Daily |
15 days |
Molecular Genetics |
| SCA-17 Mutation Analysis (SpinoCerebellar Ataxia) |
MG3074 |
5ml Blood in K2/K3 EDTA Tube (LCT) |
Daily |
15 days |
Molecular Genetics |
| SCA-2 Mutation Analysis (SpinoCerebellar Ataxia) |
MG3067 |
5ml Blood in K2/K3 EDTA Tube (LCT) |
Daily |
15 days |
Molecular Genetics |
| SCA-3 Mutation Analysis (SpinoCerebellar Ataxia) |
MG3068 |
5ml Blood in K2/K3 EDTA Tube (LCT) |
Daily |
15 days |
Molecular Genetics |
| SCA-6 Mutation Analysis (SpinoCerebellar Ataxia) |
MG3069 |
5ml Blood in K2/K3 EDTA Tube (LCT) |
Daily |
15 days |
Molecular Genetics |
| SCA-7 Mutation Analysis (SpinoCerebellar Ataxia) |
MG3070 |
5ml Blood in K2/K3 EDTA Tube (LCT) |
Daily |
15 days |
Molecular Genetics |
| SCA-8 Mutation Analysis (SpinoCerebellar Ataxia) |
MG3071 |
5ml Blood in K2/K3 EDTA Tube (LCT) |
Daily |
15 days |
Molecular Genetics |
| Sickle Cell Anemia Mutation Analysis |
MG3075 |
5ml Blood in K2/K3 EDTA Tube (LCT) |
Daily |
7 days |
Molecular Genetics |
| SLCO1B1 Genotype Analysis [Statin Induced Myopathy Risk Analysis] |
MG3078 |
5ml Blood in K2/K3 EDTA Tube (LCT) |
Daily |
7 days |
Molecular Genetics |
| Spinal Muscular Atrophy (SMA1) Exon 7 Del/Dup Analysis |
MG3076 |
5ml Blood in K2/K3 EDTA Tube (LCT) |
Daily |
2 weeks |
Molecular Genetics |
| SPINK1 Mutation Analysis [N34S] |
MG3083 |
5ml Blood in K2/K3 EDTA Tube (LCT) |
Daily |
7 days |
Molecular Genetics |
| SRY PCR for Ambiguous Genitalia |
MG3077 |
5ml Blood in K2/K3 EDTA Tube (LCT) |
Daily |
7 days |
Molecular Genetics |
| t(11;19) (q23;p13.3); (MLL-ENL), Qualitative PCR |
MG3091 |
3 mL Whole Blood / 2 mL Bone Marrow in EDTA Tube (LCT) [Clinical history is mandatory] |
Wed, Sat |
5 days |
Molecular Genetics |
| t(12;21) (p13;q22); ETV6-RUNX1(TEL-AML1), Qualitative PCR |
MG3092 |
3 mL Whole Blood / 2 mL Bone Marrow in EDTA Tube (LCT) [Clinical history is mandatory] |
Wed, Sat |
5 days |
Molecular Genetics |
| t(15;17) (q22;q12) PML-RARA Qualitative PCR |
MG3093 |
5 ml Blood or 3 ml Bone marrow in K2/K3 EDTA Tube (LCT) |
Tue, Thu, Sat |
3 days |
Molecular Genetics |
| t(15;17) (q22;q12) PML-RARA Quantitative PCR |
MG3094 |
5 ml Blood or 3 ml Bone marrow in K2/K3 EDTA Tube (LCT) |
Tue, Thu, Sat |
5 days |
Molecular Genetics |
| t(1;19) (q23;p13.3); TCF3-PBX1 (E2A-PBX1), Qualitative PCR |
MG3080 |
3 mL Whole Blood / 2 mL Bone Marrow in EDTA Tube (LCT) [Clinical history is mandatory] |
Wed, Sat |
5 days |
Molecular Genetics |
| t(4;11) (q21;q23); (MLL-AF4), Qualitative PCR |
MG3081 |
3 mL Whole Blood / 2 mL Bone Marrow in EDTA Tube (LCT) [Clinical history is mandatory] |
Wed, Sat |
5 days |
Molecular Genetics |
| t(5;12) ; PDGFRB-ETV6 Gene Rearrangement - PCR |
MG3082 |
5ml Blood / 2ml Bone Marrow in K2/K3 EDTA Tube (LCT) |
Daily |
7 days |
Molecular Genetics |
| t(8;21) ; AML1-ETO Qualitative PCR |
MG3084 |
5 ml Blood or 3 ml Bone marrow in K2/K3 EDTA Tube (LCT) |
Wed, Sat |
5 days |
Molecular Genetics |
| t(9:22) ; BCR-ABL Qualitative PCR |
MG3085 |
5 ml Blood or 3 ml Bone marrow in K2/K3 EDTA Tube (LCT) |
Tue, Thu, Sat |
3 days |
Molecular Genetics |
| t(9:22) ; BCR-ABL Quantitative (IS-International Scale) |
MG3086 |
5 ml Blood or 3 ml Bone marrow in K2/K3 EDTA Tube (LCT) |
Tue, Thu, Sat |
5 days |
Molecular Genetics |
| t(9;11) (p21-22;q23); (MLL-AF9), Qualitative PCR |
MG3087 |
3 mL Whole Blood / 2 mL Bone Marrow in EDTA Tube (LCT) [Clinical history is mandatory] |
Wed, Sat |
5 days |
Molecular Genetics |
| Tacrolimus Genotyping (CYP3A5 - *1, *3/*3) |
MG3124 |
5ml Blood in K2/K3 EDTA Tube (LCT) |
Wed, Sat |
5 days |
Molecular Genetics |
| Tamoxifen Drug Response Test (CYP2D6 Genotype Analysis) |
MG3079 |
5 ml Blood or 3 ml Bone marrow in K2/K3 EDTA Tube (LCT) |
Daily |
10 days |
Molecular Genetics |
| Thiopurine-induced Toxicity Genetic Panel (TPMT & NUDT15 Genotyping) |
MG3125 |
5ml Blood in K2/K3 EDTA Tube (LCT) |
Daily |
7 days |
Molecular Genetics |
| TPMT Genotype Analysis (Thiopurine induced Toxicity) |
MG3088 |
5ml Blood in K2/K3 EDTA Tube (LCT) |
Daily |
7 days |
Molecular Genetics |
| TRY Mutation Analysis (R278X) (Oculocutaneous Albinism (OCA) type-I) |
MG3089 |
5 ml Blood in K2/K3 EDTA Tube (LCT) |
Daily |
10 days |
Molecular Genetics |
| UGT1A1 Mutation Analysis (Gilberts Syndrome) |
MG3090 |
5ml Blood in K2/K3 EDTA Tube (LCT) |
Daily |
7 days |
Molecular Genetics |
| Waldenstrom macroglobulinemia Molecular Analysis |
MG3130 |
5 ml Blood or 3 ml Bone marrow in K2/K3 EDTA Tube (LCT), Tumor Positive Tissue or FFPE Block [Formalin fix (10 percent neutral buffered formalin) and paraffin embed tissue] |
Daily |
7 days |
Molecular Genetics |
| Warfarin Dosage Genetic Analysis |
MG3097 |
5ml Blood in K2/K3 EDTA Tube (LCT) |
Daily |
7 days |
Molecular Genetics |
| WT1 Gene Mutation Analysis (Wilm's Tumor) (Exon 7 & 9) |
MG3098 |
5 ml Blood or 3 ml Bone marrow in K2/K3 EDTA Tube (LCT) |
Daily |
10 days |
Molecular Genetics |
| Y-Chromosome Microdeletion-P16 |
MG3099 |
5ml Blood in K2/K3 EDTA Tube (LCT) |
Daily |
5 days |
Molecular Genetics |
